Sign In
Buy SGIOY
$8.74
-0.0900 (-1.02%)
At Close: Jun 03, 2026
Shionogi & Co., Ltd. (SGIOY) Q2 2024 Earnings Call Transcript
07:23pm, Tuesday, 29'th Oct 2024
Shionogi & Co., Ltd. (OTCPK:SGIOY) Q2 2024 Earnings Call Transcript October 29, 2024 2:00 AM ET Company Participants Yoshimasa Kyokawa - Vice President, Corporate Communications Isao Teshirogi - Chair
Shionogi & Co., Ltd. (SGIOY) Q1 2024 Earnings Call Transcript
09:25pm, Monday, 29'th Jul 2024
Shionogi & Co., Ltd. (OTCPK:SGIOY) Q1 2024 Earnings Conference Call July 29, 2024 4:00 AM ET Company Participants Yoshimasa Kyokawa - Vice President, Corporate Communications Masako Kudou - Vice Presi
Shionogi & Co., Ltd. (SGIOF) Q1 2023 Earnings Call Transcript
08:37pm, Monday, 31'st Jul 2023
Shionogi & Co., Ltd. (OTCPK:SGIOF) Q1 2023 Earnings Conference Call July 31, 2023 5:15 AM ET Company Participants Yoshimasa Kyokawa - VP, Corporate Communications John Keller - Senior Executive Office
Shionogi & Co., Ltd. (SGIOF) Q1 2023 Earnings Call Transcript
10:31pm, Sunday, 14'th May 2023
Shionogi & Co., Ltd. (OTCPK:SGIOF) Q1 2023 Earnings Conference Call May 10, 2023 10:00 PM ET Company Participants Yoshimasa Kyokawa - Investor Relations Isao Teshirogi - Chairman and CEO John Keller -
Shionogi: Likely The Last Viable COVID Play
10:04pm, Friday, 03'rd Mar 2023
Xocova is an approved-in-Japan COVID antiviral. Other COVID investments are causing valuations to fall as their opportunities subside.
